Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum

Japanese Journal of Clinical Oncology

Volumn 34, Issue 5, 2004, Pages 245-249

  Park, Yeon Hee ^a   Lee, Jae Cheol ^a   Kim, Cheol Hyeon ^a   Ryoo, Baek Yeol ^a   Kim, Heung Tae ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Gemcitabine; Non small cell lung cancer; Second line therapy; Vinorelbine

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; PLATINUM; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIARRHEA; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FLU LIKE SYNDROME; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TREATMENT FAILURE; TREATMENT OUTCOME; AFTERCARE; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; LUNG TUMOR; MIDDLE AGED; MORTALITY; NEUROLOGIC DISEASE; SURVIVAL RATE;

ADULT; AFTERCARE; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUTROPENIA; PACLITAXEL; PLATINUM; SURVIVAL RATE; VINBLASTINE;

EID: 3343001144     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh043     Document Type: Article

References (22)

1. Ginsberg RJ, Vokes EE, Rosenzweig K. Cancer of the lung. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology, 6th ed. Philadelphia: Lippincott-Raven 2001;925-7.
2. Sch CI, Sch KE, Park SH, Chang HJ, Ko JW, Ahn DH. Annual report of the central cancer registry in Korea-1998 (based on registered data from 124 hospitals). J Korean Cancer Assoc 2000;32:827-34.
3. Lilenbaum RC, Green MR. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J Clin Oncol 1993;11:1391-402.
4. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000;18:2095-103.
5. Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos, et al. Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens. Cancer 2001;92:2902-10.
6. Crino L, Mosconi MA, Scagliotti G, Selvaggi G, Novello S, Rinaldi M, et al. Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial. J Clin Oncol 1999;17:2081-5.
7. Rossi A, Perrone F, Barletta E, Tambaro R, Barzelloni ML, Scognamiglio F, et al. Activity of gemcitabine in cisplatin-pretreated patients with advanced non-small cell lung cancer: A phase II trial. Proc Am Soc Clin Oncol 1999;18:484a (abstract 1868).
8. Reddy GR, Gandara DR, Edelman MJ, Doroshow JH, Lau D, Lenz H, et al. Gemcitabine in platinum treated non-small cell lung cancer. Proc Am Soc Clin Oncol 1999;18:521a (abstract 2007).
9. Sculier JP, Lafitte JJ, Berghmans T, Thiriaux J, Lecomte J, Efremidis A, et al. A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. Lung Cancer 2000;29:67-73.
10. Fossella FV, De Vore R, Kerr RN, Crawford J, Natale RR, Dunphy F, et al. Randomized phase II trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. J Clin Oncol 2000;18: 2354-62.
11. Pronzato P, Landucci M, Vaira R, Vigani A, Bertelli G. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients. Anticancer Res 1994;14:1413-6.
12. Rinaldi M, Della Giulia M, Venturo, et al. Vinorelbine as single agent in the treatment of advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1994;13:360.
13. Santoro A, Maiorino, L, Santoro M. Second-line vinorelbine in the weekly monochemotherapy for the treatment of advanced non-small cell lung cancer. Lung Cancer 1994;11 (Suppl 1):130.
14. Frasci G, Lorusso V, Panza N, Comella P, Nicolella G, Bianco A, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18:2529-36.
15. Camps C, Martinez EN, Jaime AB. Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failure: a pilot study. Lung Cancer 2000;27:47-53.
16. Kosmas C, Tsavaris N, Panopoulos C, Vadiaka M, Stavroyianni N, Kourelis T, et al. Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane + platinum-based regimens. Eur J Cancer 2001;37:972-8.
17. Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, et al. The novel and effective nonplatinum, nontaxanen combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma. Cancer 2002; 95:340-53.
18. Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003;95:362-72.
19. Fossella FV. Docetaxel in second-line treatment of non-small-cell lung cancer. Clin Lung Cancer 2002;3(Suppl 2):S23-8.
20. Chen YM, Perng RP, Lee CS, Lin WC, Tsai CM, Whang-Peng J. Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy. Am J Clin Oncol 2003;26:567-70.
21. Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, et al. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-operative Oncology Group. Anticancer Res 2001;21: 3005-10.
22. Hainsworth JD, Burris HA III, Litchy S, Erland JB, Hon JK, Brierre JE, et al. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: A minnie pearl cancer research network phase II trial. Cancer 2000;88:1353-8.